FIELD: pharmacology.
SUBSTANCE: peptides of general formula (I) are proposed: A-Thr-Lys-Hyp-B-C-D-X, where A is 0, Met, Met(O), Thr, Ala, His, Phe, Lys, Gly; B is 0, Gly, Asp, Trp, Gln, Asn, Tyr, Hyp, Arg; C is 0, Arg, Phe, Tyr, Gly, His, Hyp, Lys; D is 0, Val, Gly, Tyr, Trp, Phe, His; X is OH, OCH3, NH2; where 0 is the absence of amino acid residue, provided that if A≠0, then B, and/or C, and/or D≠0, if B≠0, then C and/or D≠0, excluding tetrapeptides, as well as peptides Phe-Thr-Lys-Hyp-Gly, Thr-Lys-Hyp-Hyp-Arg, Thr-Lys-Hyp-Arg-Gly. Pharmaceutical compositions containing these peptides and their application for treatment of women with a marked decrease in libido or with a complete lack of libido, with orgasmic dysfunction, sexual dysfunction not caused by organic disorders or diseases, HSDD, FSAD or FSIAD are also proposed.
EFFECT: stimulated sexual properties and increased stability during storage.
13 cl, 6 dwg, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING FEMALE SEXUAL DYSFUNCTIONS | 2016 |
|
RU2655763C2 |
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
COMPOSITIONS AND METHODS FOR IMPROVING SEXUAL FUNCTION | 2018 |
|
RU2739916C1 |
HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
PEPTIDE ANTAGONISTS OF CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE | 2017 |
|
RU2742826C2 |
COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING PEPTIDE VERSIONS, AND METHODS OF USING THEM | 2015 |
|
RU2729161C2 |
METASTIN DERIVATIVES AND APPLICATION THEREOF | 2006 |
|
RU2430107C2 |
Authors
Dates
2017-07-21—Published
2016-10-24—Filed